Comparison of Digital versus Analog

68Ga-PSMA-11 PET/CT biochemical recurrence digital PET/CT prostate cancer

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
26 Nov 2023
Historique:
received: 10 10 2023
revised: 14 11 2023
accepted: 24 11 2023
medline: 9 12 2023
pubmed: 9 12 2023
entrez: 9 12 2023
Statut: epublish

Résumé

The aim of this study was to investigate whether the favorable characteristics of novel digital PET/CT (dPET) scanners compared to analog systems (aPET) could translate into an improved disease localization in prostate cancer (PCa) patients with early biochemical recurrence/persistence (BCR/BCP). A retrospective analysis was conducted on 440 consecutive analog (

Identifiants

pubmed: 38066776
pii: diagnostics13233535
doi: 10.3390/diagnostics13233535
pmc: PMC10706683
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Clin Nucl Med. 2021 Jun 1;46(6):465-470
pubmed: 33661210
Br J Radiol. 2021 Apr 01;94(1120):20201356
pubmed: 33571001
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):614-623
pubmed: 31792572
Eur Radiol. 2021 Oct;31(10):8030-8039
pubmed: 33856522
EJNMMI Phys. 2020 Feb 21;7(1):11
pubmed: 32086646
Eur J Hybrid Imaging. 2022 Mar 15;6(1):6
pubmed: 35288807
Clin Exp Metastasis. 2023 Apr;40(2):197-201
pubmed: 37012498
JAMA Oncol. 2019 Jun 01;5(6):856-863
pubmed: 30920593
Clin Oncol (R Coll Radiol). 2010 Feb;22(1):46-55
pubmed: 19948393
Sci Rep. 2020 Jan 15;10(1):368
pubmed: 31942032
Radiol Med. 2019 Aug;124(8):768-776
pubmed: 30771217
J Clin Oncol. 2018 Feb 10;36(5):446-453
pubmed: 29240541
Clin Exp Metastasis. 2022 Jun;39(3):443-448
pubmed: 35266063
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
Transl Oncol. 2022 Jan;15(1):101293
pubmed: 34823095
Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3257-3268
pubmed: 35217883
Urology. 2023 Dec;182:e257-e261
pubmed: 37669707
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1745-1750
pubmed: 30617960
Comput Methods Programs Biomed. 2022 Nov;226:107111
pubmed: 36108572
J Nucl Med. 2017 Sep;58(9):1511-1518
pubmed: 28450566
BJU Int. 2019 Nov;124 Suppl 1:19-30
pubmed: 31507035
Diagnostics (Basel). 2022 May 24;12(6):
pubmed: 35741119
J Nucl Med. 2019 Apr;60(4):561-567
pubmed: 30361382
EJNMMI Res. 2019 Dec 10;9(1):106
pubmed: 31823097
EJNMMI Res. 2021 Feb 28;11(1):21
pubmed: 33641046
JAMA Oncol. 2020 May 1;6(5):650-659
pubmed: 32215577
J Nucl Med. 2018 Mar;59(3):469-478
pubmed: 29123012
Eur Urol Oncol. 2021 Jun;4(3):339-355
pubmed: 33637464
J Nucl Med. 2020 Nov;61(11):1684-1690
pubmed: 32198313
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4483-4494
pubmed: 34120201
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024
pubmed: 28283702
EJNMMI Phys. 2020 Sep 3;7(1):55
pubmed: 32880792
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
J Urol. 2003 Dec;170(6 Pt 1):2274-8
pubmed: 14634395
Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4456-4462
pubmed: 34155538
EJNMMI Phys. 2021 Jan 6;8(1):1
pubmed: 33409746
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):652-664
pubmed: 31802175
J Urol. 2021 Jul;206(1):52-61
pubmed: 33634707
J Nucl Med. 2015 Sep;56(9):1447-52
pubmed: 26159585
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1626-1638
pubmed: 33604691
Eur J Nucl Med Mol Imaging. 2021 Jan;48(1):143-151
pubmed: 32405735
Ann Nucl Med. 2020 Oct;34(10):762-771
pubmed: 32623569
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1751-1752
pubmed: 30868228
Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268
pubmed: 28497198
J Clin Oncol. 2022 Oct 10;40(29):3377-3382
pubmed: 36001857
Eur J Nucl Med Mol Imaging. 2020 Nov;47(12):2804-2815
pubmed: 32314028
Theranostics. 2019 May 25;9(12):3476-3484
pubmed: 31281491
J Nucl Med. 2018 Mar;59(3):434-441
pubmed: 29242398
Cancers (Basel). 2023 Mar 29;15(7):
pubmed: 37046687
J Nucl Med. 2019 Jun;60(6):794-800
pubmed: 30442757
Clin Physiol Funct Imaging. 2022 Nov;42(6):381-388
pubmed: 35866190
Nucl Med Commun. 2023 Mar 1;44(3):187-193
pubmed: 36525002
Diagnostics (Basel). 2023 Sep 21;13(18):
pubmed: 37761380

Auteurs

Guido Rovera (G)

Nuclear Medicine Division, Department of Medical Sciences, University of Turin, 10126 Turin, Italy.

Serena Grimaldi (S)

Nuclear Medicine Division, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy.

Sara Dall'Armellina (S)

Nuclear Medicine Division, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy.

Michela Zotta (M)

Nuclear Medicine Division, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy.

Monica Finessi (M)

Nuclear Medicine Division, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy.

Roberto Passera (R)

Nuclear Medicine Division, Department of Medical Sciences, AOU Città della Salute e della Scienza di Torino, University of Turin, 10126 Turin, Italy.

Désirée Deandreis (D)

Nuclear Medicine Division, Gustave Roussy, 94805 Villejuif, France.

Classifications MeSH